Search | VHL Search Portal

1.

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19.

Aurisicchio, Luigi; Brambilla, Nadia; Cazzaniga, Marina E; Bonfanti, Paolo; Milleri, Stefano; Ascierto, Paolo A; Capici, Serena; Vitalini, Cristina; Girolami, Federica; Giacovelli, Giampaolo; Caselli, Gianfranco; Visintin, Michela; Fanti, Francesca; Ghirri, Matteo; Conforti, Antonella; Compagnone, Mirco; Lione, Lucia; Salvatori, Erika; Pinto, Eleonora; Muzi, Alessia; Marra, Emanuele; Palombo, Fabio; Roscilli, Giuseppe; Manenti, Alessandro; Montomoli, Emanuele; Cadossi, Matteo; Rovati, Lucio C.

Mol Ther ; 31(3): 788-800, 2023 03 01.

Article in English | MEDLINE | ID: mdl-36575794

2.

Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".

Caruso, Arnaldo; Caccuri, Francesca; Bugatti, Antonella; Zani, Alberto; Vanoni, Marco; Bonfanti, Paolo; Cazzaniga, Marina E; Perno, Carlo F; Messa, Cristina; Alberghina, Lilia.

J Med Virol ; 93(3): 1780-1785, 2021 03.

Article in English | MEDLINE | ID: mdl-32926453

3.

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.

Jacobs, Samuel A; Robidoux, André; Abraham, Jame; Pérez-Garcia, José Manuel; La Verde, Nicla; Orcutt, James M; Cazzaniga, Marina E; Piette, Fanny; Antolín, Silvia; Aguirre, Elena; Cortes, Javier; Llombart-Cussac, Antonio; Di Cosimo, Serena; Kim, Rim S; Feng, Huichen; Lipchik, Corey; Lucas, Peter C; Srinivasan, Ashok; Wang, Ying; Song, Nan; Gavin, Patrick G; Balousek, April D; Paik, Soonmyung; Allegra, Carmen J; Wolmark, Norman; Pogue-Geile, Katherine L.

Breast Cancer Res ; 22(1): 9, 2020 Jan 22.

Article in English | MEDLINE | ID: mdl-31969184

4.

NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2⁺ breast cancer.

Jacobs, Samuel A; Robidoux, André; Abraham, Jame; Pérez-Garcia, José Manuel; La Verde, Nicla; Orcutt, James M; Cazzaniga, Marina E; Piette, Fanny; Antolín, Silvia; Aguirre, Elena; Cortes, Javier; Llombart-Cussac, Antonio; Di Cosimo, Serena; Kim, Rim S; Feng, Huichen; Lipchik, Corey; Lucas, Peter C; Srinivasan, Ashok; Wang, Ying; Song, Nan; Gavin, Patrick G; Balousek, April D; Paik, Soonmyung; Allegra, Carmen J; Wolmark, Norman; Pogue-Geile, Katherine L.

Breast Cancer Res ; 21(1): 133, 2019 12 03.

Article in English | MEDLINE | ID: mdl-31796073

5.

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.

Alberti, Paola; Rossi, Emanuela; Argyriou, Andreas A; Kalofonos, Haralabos P; Briani, Chiara; Cacciavillani, Mario; Campagnolo, Marta; Bruna, Jordi; Velasco, Roser; Cazzaniga, Marina E; Cortinovis, Diego; Valsecchi, Maria G; Cavaletti, Guido.

Support Care Cancer ; 26(9): 3143-3151, 2018 Sep.

Article in English | MEDLINE | ID: mdl-29594485

6.

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development.

Cazzaniga, Marina E; Camerini, Andrea; Addeo, Raffaele; Nolè, Franco; Munzone, Elisabetta; Collovà, Elena; Del Conte, Alessandro; Mencoboni, Manlio; Papaldo, Paola; Pasini, Felice; Saracchini, Silvana; Bocci, Guido.

Future Oncol ; 12(3): 373-87, 2016 Feb.

Article in English | MEDLINE | ID: mdl-26584409

7.

Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.

Freyer, Gilles; Martinez-Jañez, Noelia; Kukielka-Budny, Bozena; Ulanska, Malgorzata; Bourgeois, Hugues; Muñoz, Montserrat; Morales, Serafin; Calero, Juan Bayo; Cortesi, Laura; Pintér, Tamás; Palácová, Markéta; Cherciu, Nelli; Petru, Edgar; Ettl, Johannes; de Almeida, Cécilia; Villanova, Gustavo; Raymond, Romain; Minh, Christine Ta Thanh; Rodrigues, Ana; Cazzaniga, Marina E.

Breast ; 74: 103681, 2024 Apr.

Article in English | MEDLINE | ID: mdl-38377732

8.

Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial.

Malorni, Luca; Bianchini, Giampaolo; Caputo, Roberta; Zambelli, Alberto; Puglisi, Fabio; Bianchi, Giulia V; Del Mastro, Lucia; Paris, Ida; Montemurro, Filippo; Allegrini, Giacomo; Colleoni, Marco; Tamberi, Stefano; Zamagni, Claudio; Cazzaniga, Marina E; Orditura, Michele; Guarneri, Valentina; Castelletti, Daniela; Benelli, Matteo; Di Marino, Mariacristina; Arpino, Grazia; De Laurentiis, Michelino.

Eur J Cancer ; 186: 1-11, 2023 06.

Article in English | MEDLINE | ID: mdl-37003098

9.

In reply to Kadri Altundag.

Cazzaniga, Marina E.

Breast Cancer Res Treat ; 161(2): 387, 2017 01.

Article in English | MEDLINE | ID: mdl-27873134

10.

Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH project.

Cazzaniga, Marina E; Ciruelos, E; Fabi, A; Garcia-Saenz, J; Lindman, H; Mavroudis, D; Schem, C; Steger, G; Timotheadou, E; Zaman, K; Torri, V.

Cancer Chemother Pharmacol ; 83(2): 301-318, 2019 02.

Article in English | MEDLINE | ID: mdl-30460489

11.

Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project.

Cazzaniga, Marina E; Munzone, Elisabetta; Bocci, Guido; Afonso, Noémia; Gomez, Patricia; Langkjer, Sven; Petru, Edgar; Pivot, Xavier; Sánchez Rovira, Pedro; Wysocki, Piotr; Torri, Valter.

Adv Ther ; 36(2): 381-406, 2019 02.

Article in English | MEDLINE | ID: mdl-30565179

12.

Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?

Cazzaniga, Marina E; Munzone, Elisabetta; Montagna, Emilia; Pappagallo, Giovanni.

Expert Rev Anticancer Ther ; 18(8): 805-814, 2018 08.

Article in English | MEDLINE | ID: mdl-29902087

13.

Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.

Bernardo, Antonio; Palumbo, Raffaella; Pedersini, Rebecca; Rota Caremoli, Elena; Gambaro, Anna Rita; Ferzi, Antonella; Riva, Francesca; Grasso, Donatella; Danova, Marco; Tarenzi, Emiliana; Torri, Valter; Cazzaniga, Marina E.

Clin Breast Cancer ; 17(6): 433-440, 2017 10.

Article in English | MEDLINE | ID: mdl-28366406

14.

Efficacy and safety of vinorelbine-capecitabine oral metronomic combination in elderly metastatic breast cancer patients: VICTOR-1 study.

Cazzaniga, Marina E; Torri, Valter; Riva, Francesca; Porcu, Luca; Cicchiello, Federica; Capici, Serena; Cortinovis, Diego; Digiacomo, Nunzio; Bidoli, Paolo.

Tumori ; 103(1): e4-e8, 2017 Jan 21.

Article in English | MEDLINE | ID: mdl-27647223

15.

Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study.

Cazzaniga, Marina E; Dogliotti, Luigi; Cascinu, Stefano; Barni, Sandro; Labianca, Roberto; Chiara, Silvana; Conte, Pier Franco; Gasparini, Giampietro; Pasetto, Lara; Torri, Valter.

Oncology ; 71(5-6): 374-81, 2006.

Article in English | MEDLINE | ID: mdl-17785994

16.

Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer.

Bidoli, Paolo; Cortinovis, Diego L; Colombo, Ilaria; Crippa, Alessandra; Cicchiello, Federica; Villa, Federica; Cazzaniga, Marina E; Altomare, Gianfranco.

J Thorac Oncol ; 5(10): 1662-3, 2010 Oct.

Article in English | MEDLINE | ID: mdl-20871265

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: